CDK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.804600E-01
Normal-vs-Stage2
1.998410E-01
Normal-vs-Stage3
5.219600E-01
Normal-vs-Stage4
6.862600E-01
Stage1-vs-Stage2
5.595800E-01
Stage1-vs-Stage3
9.415200E-01
Stage1-vs-Stage4
7.311400E-01
Stage2-vs-Stage3
5.606600E-01
Stage2-vs-Stage4
3.438200E-01
Stage3-vs-Stage4
7.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.539000E-01
Normal-vs-AfricanAmerican
3.906400E-01
Normal-vs-Asian
6.239800E-02
Caucasian-vs-AfricanAmerican
7.071000E-01
Caucasian-vs-Asian
8.825600E-01
AfricanAmerican-vs-Asian
5.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.230400E-01
Normal-vs-Female
2.726000E-01
Male-vs-Female
9.273800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.811400E-01
Normal-vs-Age(41-60Yrs)
2.318800E-01
Normal-vs-Age(61-80Yrs)
2.435600E-01
Normal-vs-Age(81-100Yrs)
1.958750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.458600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.611600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.461400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.053400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.580400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.397000E-01
Normal-vs-Daily Drinker
2.260000E-01
Normal-vs-Weekly Drinker
1.971580E-01
Normal-vs-Occasional Drinker
2.155600E-01
Normal-vs-Social Drinker
2.571400E-01
Non Drinker-vs-Daily Drinker
7.268600E-01
Non Drinker-vs-Weekly Drinker
6.559600E-01
Non Drinker-vs-Occasional Drinker
8.616400E-01
Non Drinker-vs-Social Drinker
5.358600E-01
Daily Drinker-vs-Weekly Drinker
8.830200E-01
Daily Drinker-vs-Occasional Drinker
8.668000E-01
Daily Drinker-vs-Social Drinker
3.618400E-01
Weekly Drinker-vs-Occasional Drinker
7.615600E-01
Weekly Drinker-vs-Social Drinker
3.007800E-01
Occasional Drinker-vs-Social Drinker
4.341800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.605000E-01
Normal-vs-Grade 2
8.239600E-01
Normal-vs-Grade 3
8.690400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.413500E-04
Grade 1-vs-Grade 3
1.396150E-04
Grade 1-vs-Grade 4
6.605000E-01
Grade 2-vs-Grade 3
3.707000E-01
Grade 2-vs-Grade 4
8.239600E-01
Grade 3-vs-Grade 4
8.690400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.177400E-01
Normal-vs-NonDiabetic
2.145800E-01
Diabetic-vs-NonDiabetic
1.433580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.568100E-02
Normal-vs-NoPancreatitis
2.854400E-01
Pancreatitis-vs-NoPancreatitis
2.963400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.860820E-01
Normal-vs-N1
2.421600E-01
N0-vs-N1
6.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.657590E-02
Normal-vs-TP53-NonMutant
3.512600E-01
TP53-Mutant-vs-TP53-NonMutant
6.68010002868868E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
